Dyne Therapeutics, Inc.
DYN • NASDAQ • Stock Fundamentals
Dyne Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO John G. Cox, with a market cap of $3.0B.
Market Cap$3.0B
Employees143.0
CEOJohn G. Cox
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026
View reportNext EarningsJul 27, 2026 · in a monthBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Dyne Therapeutics, Inc. FAQ
Common questions about Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. (DYN) has a market capitalization of $3.0B and trades on NASDAQ.
Dyne Therapeutics, Inc. has approximately 143 employees.